Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on August 27, 2009
J Am Soc Nephrol 20: 2181-2189, 2009
© 2009 American Society of Nephrology
doi: 10.1681/ASN.2009040379

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
ASN.2009040379v1
20/10/2181    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Mollet, G.
Right arrow Articles by Esquivel, E. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mollet, G.
Right arrow Articles by Esquivel, E. L.
Related Collections
Right arrowRelated Articles

BASIC RESEARCH

Podocin Inactivation in Mature Kidneys Causes Focal Segmental Glomerulosclerosis and Nephrotic Syndrome

Géraldine Mollet*,{dagger}, Julien Ratelade*,{dagger}, Olivia Boyer*,{dagger},{ddagger}, Andrea Onetti Muda*,§, Ludivine Morisset*,{dagger}, Tiphaine Aguirre Lavin*,{dagger}, David Kitzis*,{dagger}, Margaret J. Dallman||, Laurence Bugeon||, Norbert Hubner, Marie-Claire Gubler*,{dagger}, Corinne Antignac*,{dagger},** and Ernie L. Esquivel*,{dagger}

*INSERM, U574, Hôpital Necker-Enfants Malades, Paris, France;
{dagger}Faculté de Médecine René Descartes, Université Paris Descartes, Paris, France;
{ddagger}Pediatric Nephrology Department and
**Department of Genetics, Hôpital Necker-Enfants Malades, Assistance Publique-Hôpitaux de Paris, Paris, France;
§Department of Pathology, Campus Biomedico University, Rome, Italy;
||Department of Biological Sciences, Imperial College London, London, England; and
Max-Delbruck Center for Molecular Medicine, Berlin, Germany

Correspondence: Dr. Corinne Antignac, INSERM U574, 6ème étage, Tour Lavoisier, Hôpital Necker-Enfants Malades, 149 rue de Sèvres, 75015 Paris, France. Phone: +33-1-4449-4552; Fax: +33-1-4449-0290; E-mail: corinne.antignac{at}inserm.fr

Received for publication April 8, 2009. Accepted for publication June 10, 2009.

Podocin is a critical component of the glomerular slit diaphragm, and genetic mutations lead to both familial and sporadic forms of steroid-resistant nephrotic syndrome. In mice, constitutive absence of podocin leads to rapidly progressive renal disease characterized by mesangiolysis and/or mesangial sclerosis and nephrotic syndrome. Using established Cre-loxP technology, we inactivated podocin in the adult mouse kidney in a podocyte-specific manner. Progressive loss of podocin in the glomerulus recapitulated albuminuria, hypercholesterolemia, hypertension, and renal failure seen in nephrotic syndrome in humans. Lesions of FSGS appeared after 4 wk, with subsequent development of diffuse glomerulosclerosis and tubulointerstitial damage. Interestingly, conditional inactivation of podocin at birth resulted in a gradient of glomerular lesions, including mesangial proliferation, demonstrating a developmental stage dependence of renal histologic patterns of injury. The development of significant albuminuria in this model occurred only after early and focal foot process effacement had progressed to diffuse involvement, with complete absence of podocin immunolabeling at the slit diaphragm. Finally, we identified novel potential mediators and perturbed molecular pathways, including cellular proliferation, in the course of progression of renal disease leading to glomerulosclerosis, using global gene expression profiling.


Related Articles

This Month's Highlights
J. Am. Soc. Nephrol. 2009 20: A12. [Full Text] [PDF]

Surprising Results following Conditional Podocyte Inactivation
Martin R. Pollak
J. Am. Soc. Nephrol. 2009 20: 2086-2088. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
M. R. Pollak
Surprising Results following Conditional Podocyte Inactivation
J. Am. Soc. Nephrol., October 1, 2009; 20(10): 2086 - 2088.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP